Skip to content
Agentic OS
Menu

Intelligence / Healthtech / Device Recalls / Medtronic, INC.

QualityClass II recall4 Nov 2026

Medtronic, INC.

4 Nov 2026: Class II recall · OmniaSecure Model 3930M, LEAD 3930M74 74 CM DF4 MR 3930M74 LEAD 3930M79 79 CM DF4 MR 3930M79 The Medtronic OmniaSecure" Model 3930M lead is a steroid eluting, i. Recorded in the openFDA device enforcement reports.

View the source record

Reported
4 Nov 2026
Recall Class
Class II
Product
OmniaSecure Model 3930M, LEAD 3930M74 74 CM DF4 MR 3930M74 LEAD 3930M79 79 CM DF4 MR 3930M79 The Medtronic OmniaSecure" Model 3930M lead is a steroid eluting, i
Reason
Affected leads require additional engineering evaluation due to complaints regarding difficulty in achieving fixation during implantation. Potential harm of tissue trauma due to implant difficulty.
Country
United States
Status
Ongoing
Reference
Z-0285-2027
Location
Mounds View, MN
What this signal means

A recall puts quality, regulatory, field service and communications under pressure at once.

  1. Class II leads with 660 of 741, then Class I (68).
  2. 235 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Medtronic, INC.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this quality signal, for your approval.

Start free

Across AOS Research

Other records for Medtronic, INC. in our registers.

More in Class II

Device Recalls

See all

Source: openFDA device enforcement reports, data to 18 Nov 2026. Device recalls classified by FDA, by report date. Class I is the most serious. AOS shows what the public record says; it does not verify or endorse the company.